Dark

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Jun 12, 2026 10:29:59 AM EDT

5.39USD-5.185%(-0.30)5,802

4.49Bid 6.33Ask 1.84Spread

Pre-market

Jun 9, 2026 8:56:30 AM EDT

5.19USD-8.858%(-0.50)0

After-hours

Jun 11, 2026 4:00:30 PM EDT

5.69USD+6.554%(+0.35)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

5.15M

Industry

Biotechnology

Last Split

May 15, 20251for28reverse

RNAZ Stats

Avg. Vol. 10 Day

273,101

Avg. Vol. 30 Day

99,031

Employees

Market Cap

5,150,637

Shares Out.

950,302

On/Off Exchange

59%/41%

6 Month Beta

0.47

1 Year Beta

0.19

2 Year Beta

0.28

3 Year Beta

-0.08

52 Week Low

3.82

52 Week High

20.99

SMA50

7.23

SMA200

9.28

1 Week

-3.21%

1 Month

-19.47%

3 Month

-44.69%

6 Month

-43.01%

1 Year

-24.77%

2 Year

-99.52%

5 Year

-100.00%

Profile

transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.

RNAZ Stock Summary

TransCode Therapeutics, Inc. Common Stock (NASDAQ:RNAZ) stock price today is $5.39, and today's volume is 5,802. RNAZ is down -5.185% today. The 30 day average volume is 99,031. RNAZ market cap is 5.15M with 950,302 shares outstanding.

.dark-mode .VhFRXq{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .VhFRXq{ color: #333333; background-color: white; border: 2px solid #333333; }RNAZTransCode Therapeutics, Inc. Common Stockstock NASDAQ

RNAZ Stock Summary

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ